|
|
||||||||





*
Departments of Internal Medicine and Pediatrics, Blood and Marrow Transplantation Program, University of Michigan, Ann Arbor, MI 48109;
Division of Pediatric Oncology, Dana-Farber Cancer Institute,
Department of Pathology, Brigham and Womens Hospital,
Division of Pediatric Pulmonology, Childrens Hospital, Boston, MA, 02115; and
¶ Department of Pathology, University of Florida School of Medicine, Gainesville, FL 32610
Idiopathic pneumonia syndrome (IPS) is a major complication of
allogeneic bone marrow transplantation (BMT). We have shown that
experimental IPS is associated with increased levels of LPS and TNF-
in the bronchoalveolar lavage (BAL) fluid. We hypothesized that the
deleterious effects of these inflammatory mediators in the lung may be
linked to gut injury that develops after BMT. To test this hypothesis,
we used mouse strains that differ in their sensitivity to LPS as donors
in an experimental BMT model. Lethally irradiated C3FeB6F1
hosts received BMT from either LPS-sensitive or LPS-resistant donors.
Five weeks after BMT, LPS-resistant BMT recipients had significantly
less lung injury compared with recipients of LPS-sensitive BMT. This
effect was associated with reductions in TNF-
secretion (both in
vitro and in vivo), BAL fluid LPS levels, and intestinal injury. The
relationship between TNF-
, gut toxicity, and lung injury was
examined further by direct cytokine blockade in vivo; systemic
neutralization of TNF-
resulted in a significant reduction in gut
histopathology, BAL fluid LPS levels, and pulmonary dysfunction
compared with control-treated animals. We conclude that donor
resistance to endotoxin reduces IPS in this model by decreasing the
translocation of LPS across the intestinal border and systemic and
pulmonary TNF-
production. These data demonstrate a potential
etiologic link between gut and lung damage after BMT and suggest that
methods that reduce inflammatory responses to LPS, and specifically,
those that protect the integrity of the gut mucosa, may be effective in
reducing IPS after BMT.
This article has been cited by other articles:
![]() |
G. A. Yanik, V. T. Ho, J. E. Levine, E. S. White, T. Braun, J. H. Antin, J. Whitfield, J. Custer, D. Jones, J. L. M. Ferrara, et al. The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation Blood, October 15, 2008; 112(8): 3073 - 3081. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. A. MacDonald, R. D. Kuns, V. Rowe, E. S. Morris, T. Banovic, H. Bofinger, B. O'Sullivan, K. A. Markey, A. L. Don, R. Thomas, et al. Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during GVHD Blood, June 1, 2007; 109(11): 5049 - 5057. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Hildebrandt, K. M. Olkiewicz, S. Choi, L. A. Corrion, S. G. Clouthier, C. Liu, J. S. Serody, and K. R. Cooke Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation Blood, March 15, 2005; 105(6): 2249 - 2257. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Johnson, T. T. T. Le, C. A. Dobbin, T. Banovic, C. B. Howard, F. d. M. L. Flores, D. Vanags, D. J. Naylor, G. R. Hill, and A. Suhrbier Heat Shock Protein 10 Inhibits Lipopolysaccharide-induced Inflammatory Mediator Production J. Biol. Chem., February 11, 2005; 280(6): 4037 - 4047. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Hildebrandt, L. A. Corrion, K. M. Olkiewicz, B. Lu, K. Lowler, U. A. Duffner, B. B. Moore, W. A. Kuziel, C. Liu, and K. R. Cooke Blockade of CXCR3 Receptor:Ligand Interactions Reduces Leukocyte Recruitment to the Lung and the Severity of Experimental Idiopathic Pneumonia Syndrome J. Immunol., August 1, 2004; 173(3): 2050 - 2059. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Hildebrandt, K. M. Olkiewicz, L. A. Corrion, Y. Chang, S. G. Clouthier, C. Liu, and K. R. Cooke Donor-derived TNF-{alpha} regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation Blood, July 15, 2004; 104(2): 586 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Mapara and M. Sykes Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking Tolerance J. Clin. Oncol., March 15, 2004; 22(6): 1136 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Hildebrandt, U. A. Duffner, K. M. Olkiewicz, L. A. Corrion, N. E. Willmarth, D. L. Williams, S. G. Clouthier, C. M. Hogaboam, P. R. Reddy, B. B. Moore, et al. A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation Blood, March 15, 2004; 103(6): 2417 - 2426. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Socie, J.-Y. Mary, M. Lemann, M. Daneshpouy, P. Guardiola, V. Meignin, L. Ades, H. Esperou, P. Ribaud, A. Devergie, et al. Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression Blood, January 1, 2004; 103(1): 50 - 57. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |